
Conference Coverage
about 22 hours ago
Payment Models Taking Shape for Advanced Therapies: Fran Gregory, PharmDabout 22 hours ago
The Pharmacist as the CLL Communication Hub: Karen Fancher, PharmD, BCOPabout 22 hours ago
Access, Automation, and What Works in Pharmacy: Ryan Telford, PharmDabout 24 hours ago
Amplify the Patient Voice in Community Oncology Care: Rose Gerber, MSLatest Content

Driving Value-Based Practice Transformation Through Care Management

FAQs on Colorectal Cancer, Treatment, and Prevention

Taking the Giant Leap Into CAR T: Managing Financial and Administrative Challenges

Potential Expiration of Tax Credits and Medicaid Unwinding Threaten Progress in Health Equity

Partnerships Power Access to Advanced Oncology Therapies

Shorts










Podcasts
Center on Health Equity & Access
All News

Experts examined oncology care innovation, access gaps to CAR T-cell therapy, advances in myeloma care, and partnerships in value-based care.

FIT-DNA modestly improved CRC screening in CHCs, but uptake and follow-up colonoscopy rates remained low.

Specialty pharmacies play a critical role in connecting patients with assistance programs to combat growing financial complexities.

Patients with advanced glaucoma had better outcomes when treated with trabeculectomy rather than using medication first.

At AXS26, leaders shared the hard-won organizational, strategic, and operational lessons from rounds 1, 2, and 3 of the Medicare Drug Price Negotiation Program.

Policy experts discuss how PBM reforms came together, what changes are on the horizon, and what threats are looming for community oncology.

Experts examine what is working in production, where the guardrails are being tested, and why the most transformative chapter of AI in health care hasn’t started yet.

Bringing these curative treatments to more patients means making them available at the community practice level. But that's a big lift, according to experts who spoke at a COA session.

A study using Flatiron Health and SEER data shows community oncology patients with metastatic breast cancer and metastatic NSCLC live longer, highlighting COA-backed local care advantages.

Wastewater SARS-CoV-2 levels correlated with hospital COVID-19 cases, supporting targeted screening of asymptomatic patients.






















